{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:44:55Z","timestamp":1764402295398},"reference-count":66,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.09.039","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"1343-1357","source":"Crossref","is-referenced-by-count":35,"title":["A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety"],"prefix":"10.1016","volume":"22","author":[{"given":"Eric","family":"Mallet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd H","family":"Belohradsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Gothefors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Camier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Carri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcler","family":"Kanra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Hoffenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Langue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Undreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl-Erik","family":"Flodmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Stojanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Liese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Sch\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Hessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.09.039_BIB1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Pediatrics 1999;103:1064\u201377.","DOI":"10.1542\/peds.103.5.1064"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/biol.1994.1070","article-title":"Are different combined vaccines needed in different parts of Europe? A point of view from a Northern European country","volume":"22","author":"R\u00fcmke","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/biol.1994.1048","article-title":"Epidemiological views into possible components of paediatric combined vaccines in 2015","volume":"22","author":"Eskola","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-3955(05)70209-1","article-title":"Acellular pertussis vaccines","volume":"47","author":"Decker","year":"2000","journal-title":"Pediatr. Clin. North. Am."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2003.09.039_BIB5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2003.09.039_BIB6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serological response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB7","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/00006454-199704001-00004","article-title":"Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials","volume":"16","author":"Cherry","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006454-199711000-00007","article-title":"Efficacy of a two-component acellular pertussis vaccine in infants","volume":"16","author":"Liese","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00006454-199705000-00011","article-title":"The acellular pertussis vaccine trials: an interpretation","volume":"16","author":"Plotkin","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006454-199510000-00003","article-title":"Inactivated poliomyelitis vaccine for the United States: a missed vaccination opportunity","volume":"14","author":"Plotkin","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2003.09.039_BIB11","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1097\/00006454-199809001-00007","article-title":"Haemophilus influenzae type b disease and vaccination in Europe: lessons learned","volume":"17","author":"Peltola","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00006454-199305000-00036","article-title":"Epidemiology of hepatitis B","volume":"12","author":"Shapiro","year":"1993","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB13","unstructured":"WHO and Viral Hepatitis Prevention Board. Prevention and control of hepatitis B in the community. Communicable diseases series no. 1; 1996."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0264-410X(99)00331-X","article-title":"Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze\u2013dried Haemophilus influenzae type b vaccine (DTaP\u2013IPV\/\/PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life","volume":"18","author":"Kanra","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB15","unstructured":"The European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products. Points to consider on the reduction, elimination or substitution of thiomersal in vaccines. CPMP\/BWP\/2517\/00, London: EMEA; 26 April 2001."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00006454-200012000-00001","article-title":"Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants","volume":"19","author":"Mallet","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB17","unstructured":"Lagos R, Mu\u00f1oz A, Fabre P, et al. Safety and immunogenicity of 3 consistency lots of a liquid hexavalent vaccine given at 2, 4 and 6 months of age. In: Proceedings of the 37th Annual Meeting of the Infectious Diseases Society of America. Philadelphia USA, 18\u201321 November 1999 [abstract]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB18","unstructured":"Camier P, Langue J, Undreiner F, et al. Immunogenicity and safety of a liquid hexavalent combined vaccine administered to healthy infants at 2, 3, 4 or 2, 4, 6 months and at 15\u201317 months. Nordwijk. In: Proceedings of the European Society for Paediatric Infectious Diseases. The Netherlands, 3\u20135 May 2000 [abstract]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00006454-199804000-00006","article-title":"Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants","volume":"17","author":"Lagos","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00006454-199811000-00013","article-title":"Safety and immunogenicity of a combined diphtheria\u2013tetanus\u2013acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2\u20134\u20136\u201313 or 3\u20135\u201312 months of age","volume":"17","author":"Carlsson","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006454-199709000-00009","article-title":"Vaccine antigen interactions after a combination diphtheria\u2013tetanus toxoid\u2013acellular pertussis\/purified capsular polysaccharide of Haemophilus influenzae type b\u2013tetanus toxoid vaccine in two-, four- and six-month-old infants","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB22","unstructured":"Mallet E, Fabre P, Pines E, et al. Comparison of a liquid hexavalent vaccine to licensed PENTAVAC\u2122 and HB-VAX\u00ae vaccines in French infants. In: Proceedings of the Abstracts of the 37th IDSA Annual Meeting; Clin Infect Dis 1999;29:abstract 642."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB23","unstructured":"Silier T, Langue J, Blondeau C, Fritzell B. Simultaneous administration of DTaP\u2013IPV\u2013Act\u2013HIB and MMR vaccines at 14 to 16 months. In: Proceedings of the European Society for Paediatric Infectious Disease. Helsing\u00f8r, Denmark, 18\u201321 June 1996 [abstract 22]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0264-410X(01)00344-9","article-title":"Large scale safety study of a liquid hexavalent vaccine (D-T-acP\u2013IPV\u2013PRPT\u2013HBs) given at 2, 4, 6 and 12 to 14 months of age","volume":"20","author":"Liese","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB25","unstructured":"Carri\u00e8re JP, Giard P, Muller JM, et al. Safety and reactogenicity of a liquid hexavalent combined vaccine administered to healthy toddlers aged 16\u201320 months. In: Proceedings of the European Society for Paediatric Infectious Diseases. Nordwijk, The Netherlands, 3\u20135 May 2000 [abstract]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0264-410X(98)00273-4","article-title":"Priming effect, immunogenicity and safety of an Haemophilus influenzae type b\u2013tetanus toxoid conjugate (PRP-T) and diphtheria\u2013tetanus\u2013acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey","volume":"17","author":"Hoppenbrouwers","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0264-410X(97)00303-4","article-title":"Safety and immunogenicity of an Haemophilus influenzae type b\u2013tetanus toxoid conjugate (PRP-T) and diphtheria\u2013tetanus\u2013pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile","volume":"16","author":"Hoppenbrouwers","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB28","unstructured":"Liese JG, Harzer E, Hosbach P, Froeschle J, Meschiewitz CK, Belohradsky BH. Hib antibody response of a combined DTaP-PRP-T conjugate vaccine compared to separate injections in infants. In: Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, 15\u201318 September 1996. Washington, DC: American Society for Microbiology; 1996. p. 162 [abstract G-105]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB29","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(96)04356-5","article-title":"Randomized trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine","volume":"348","author":"Eskola","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB30","unstructured":"Dagan R, Agbaria K, Piglansky L, Melamed R, Willems P, Grossi A. Immunogenicity of a combined diphtheria, tetanus, acellular pertussis, inactivated poliovirus and H. influenzae type b conjugate vaccine (DTPa\u2013IPV\u2013Hib) in infants. In: Proceedings of the 36th International Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, 15\u201318 September 1996. Washington, DC: American Society for Microbiology; 1996. p. 154 [abstract G-59]."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199011153232010","article-title":"Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D","volume":"323","author":"Robbins","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB32","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria\u2013tetanus\u2013pertussis-containing acellular pertussis","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","article-title":"A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease","volume":"323","author":"Eskola","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpedi.1994.02170060074015","article-title":"Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy","volume":"148","author":"Peltola","year":"1994","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB35","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","article-title":"The efficacy in Navajo Indians of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis-outer-membrane protein complex","volume":"324","author":"Santosham","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(96)06392-1","article-title":"Vaccine failures after primary immunisation with Haemophilus influenzae type b conjugate vaccine without booster","volume":"349","author":"Booy","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB38","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/bmj.316.7144.1569","article-title":"Immunological response to conjugate vaccines in infants: follow-up study","volume":"316","author":"Goldblatt","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","article-title":"Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61080 children","volume":"10","author":"Black","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB40","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria\u2013tetanus toxoid and acellular pertussis vaccine for primary and booster immunizations","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(97)84511-2","article-title":"Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)","volume":"16","author":"Bell","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB43","first-page":"1100","article-title":"High antibody responses to booster doses of either Haemophilus influenzae type b capsular polysaccharide or conjugate vaccines after primary immunization with conjugate vaccine","volume":"147","author":"K\u00e4hyty","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s004310050544","article-title":"Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters in children primed with a tetanus-conjugate Hib\u2013DTPa\u2013HBV combined vaccine","volume":"156","author":"Zepp","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00006454-200108000-00010","article-title":"Haemophilus influenzae type b disease: impact and effectiveness of diphtheria\u2013tetanus toxoids\u2013acellular pertussis (-inactivated poliovirus)\/H. influenzae type b combination vaccines","volume":"20","author":"Schmitt","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.1840010502","article-title":"A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report","volume":"1","author":"Szmuness","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-97-3-362","article-title":"The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multi-center efficacy trial among homosexual men","volume":"97","author":"Francis","year":"1982","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB48","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bmj.286.6374.1305","article-title":"Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial","volume":"286","author":"Coutinho","year":"1983","journal-title":"Br. Med. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00006454-199511000-00014","article-title":"Primary vaccination of infants with a combined diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B vaccine","volume":"14","author":"Kanra","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB50","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/516154","article-title":"Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine","volume":"25","author":"Pichichero","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00006454-199706000-00010","article-title":"Safety and immunogenicity of a bivalent Haemophilus influenzae type b\/hepatitis B vaccine in healthy infants","volume":"16","author":"West","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0264-410X(95)00228-S","article-title":"Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age","volume":"14","author":"Greenberg","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3476(94)70123-7","article-title":"Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four and twelve or fifteen months of age","volume":"125","author":"Keyserling","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory","volume":"19","author":"Banatvala","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0923-2516(97)89893-7","article-title":"Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine","volume":"148","author":"Da Villa","year":"1997","journal-title":"Res. Virol."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB56","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0264-410X(93)90145-N","article-title":"Anti-HBs and immunological memory to HBV vaccine: implication for booster timing","volume":"11","author":"Resti","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(97)00233-8","article-title":"A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults","volume":"16","author":"Marsano","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmv.1890300314","article-title":"Very low dose hepatitis B vaccination in the newborn: anamnestic response to booster at four years","volume":"30","author":"Moyes","year":"1990","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/175.3.674","article-title":"Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Results of a 10-year study","volume":"175","author":"Wainwright","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/314578","article-title":"What level of hepatitis B antibody is protective?","volume":"179","author":"Jack","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(96)90398-0","article-title":"Acellular pertussis vaccines: new vaccines for an old disease","volume":"347","author":"Poland","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB62","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(90)90246-I","article-title":"Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial","volume":"8","author":"Storsaeter","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0264-410X(92)90002-2","article-title":"Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance","volume":"10","author":"Storsaeter","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.039_BIB65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/infdis\/170.3.705","article-title":"Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren","volume":"170","author":"He","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.039_BIB66","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T13:31:42Z","timestamp":1682602302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":66,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007357"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.09.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}